Clinical Trials Directory

Trials / Unknown

UnknownNCT02579304

Diagnostic Value of Transbronchial Lung Cryobiopsy

Feasibility, Safety and Diagnostic Value of Transbronchial Lung Cryobiopsy in the Work-up of Diffuse Interstitial Lung Diseases.

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Evaluating the diagnostic value of transbronchial lung cryobiopsy (TBLC) as well as its procedural feasibility and safety in a prospective series of 20 patients with diffuse interstitial lung diseases (DILD) who are referred for invasive histopathological diagnostics

Detailed description

Before one is able to state that TBLC is a technique that is an alternative for VATS biopsy, the diagnostic value of TBLC should be assessed and the value of the histopathological sampling should be compared with what is achieved by surgical lung biopsy. For this purpose direct comparison between VATS biopsy and TBLC is unavoidable. By including TBLC in the work-up of patients with DILD in which histopathological assessment is indicated (as proposed by MDD), we want to assess 3 major points of concern. Agreement for the histopathological diagnosis between VATS biopsy and TBLC. Value of TBLC in the specific diagnosis in ILD.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransbronchial lung cryobiopsybronchoscopic sampling

Timeline

Start date
2019-01-01
Primary completion
2022-12-01
Completion
2023-06-01
First posted
2015-10-19
Last updated
2018-05-24

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02579304. Inclusion in this directory is not an endorsement.